Related News
'Excellent prognosis' for Apple co-founder
By Janet Blake |
June 25, 2009, Thursday
|
Print Edition
Print Edition
APPLE co-founder and CEO Steve Jobs has an "excellent prognosis" after receiving a liver transplant at a Tennessee hospital in the United States, a doctor confirmed on Tuesday.
"He received a liver transplant because he was ... the sickest patient on the waiting list at the time a donor organ became available," said Dr James D. Eason, chief of transplantation at Methodist University Hospital Transplant Institute in Memphis. "Mr Jobs is now recovering well and has an excellent prognosis."
Eason said on the hospital's Website that when Jobs received the transplant, he was in end-stage liver disease.
Eason did not reveal when the operation took place, citing patient privacy. However, The Wall Street Journal reported it was two months ago.
Apple did not confirm the WSJ report, and has said only that Jobs is looking forward to returning to Apple - which he started in 1976 - at the end of this month.
Eason said the hospital could not reveal further information on the specifics of the transplant.
"That's all that we are giving out at this time," hospital spokeswoman Ruth Ann Hale said.
Wall Street has grappled with the implications of Jobs' illness since August 2004, when investors learned the CEO had kept a cancer diagnosis secret until after he underwent surgery. The company's past silence on matters of Jobs' health made shareholders jittery when he appeared increasingly, even alarmingly, thin last year.
Investors sent the stock tumbling 5 percent to its lowest point in a year on a rumor last October that Jobs had suffered a heart attack.
Apple's stock has weathered the recession better than most of its competitors.
"He received a liver transplant because he was ... the sickest patient on the waiting list at the time a donor organ became available," said Dr James D. Eason, chief of transplantation at Methodist University Hospital Transplant Institute in Memphis. "Mr Jobs is now recovering well and has an excellent prognosis."
Eason said on the hospital's Website that when Jobs received the transplant, he was in end-stage liver disease.
Eason did not reveal when the operation took place, citing patient privacy. However, The Wall Street Journal reported it was two months ago.
Apple did not confirm the WSJ report, and has said only that Jobs is looking forward to returning to Apple - which he started in 1976 - at the end of this month.
Eason said the hospital could not reveal further information on the specifics of the transplant.
"That's all that we are giving out at this time," hospital spokeswoman Ruth Ann Hale said.
Wall Street has grappled with the implications of Jobs' illness since August 2004, when investors learned the CEO had kept a cancer diagnosis secret until after he underwent surgery. The company's past silence on matters of Jobs' health made shareholders jittery when he appeared increasingly, even alarmingly, thin last year.
Investors sent the stock tumbling 5 percent to its lowest point in a year on a rumor last October that Jobs had suffered a heart attack.
Apple's stock has weathered the recession better than most of its competitors.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证：沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证：31120180004
- |
- 网络视听许可证：0909346
- |
- 广播电视节目制作许可证：沪字第354号
- |
- 增值电信业务经营许可证：沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
